Considerations in producing preferentially reduced half-antibody fragments

Area of Science:

• Immunology
• Biochemistry
• Biotechnology

Background:

• Half-antibody fragments offer oriented reactivity for applications like biosensing and drug delivery.
• Existing antibody reduction protocols are generalized, lacking optimization for specific IgG subclasses or host origins.
• Structural variations in IgG molecules necessitate tailored reduction strategies.

Purpose of the Study:

• To investigate and optimize preferential reduction protocols for generating half-antibody fragments from different IgG subclasses.
• To determine the impact of pH and reductant choice on the yield and specificity of half-antibody fragments.
• To confirm the retention of binding activity in produced half-antibody fragments.

Main Methods:

• Investigated preferential reduction of sheep anti-digoxin, rabbit anti-Escherichia coli, and rabbit anti-myoglobin IgG antibodies.
• Utilized 2-mercaptoethylamine (2-MEA) and tris(2-carboxyethyl)phosphine (TCEP) as reducing agents.
• Quantitatively determined fragment yields using SDS-PAGE analysis and optimized conditions by varying pH and reductant concentrations.

Main Results:

• Lowering the pH of reduction mixtures increased half-antibody fragment yields.
• Antibody susceptibility to reductants varied, with sheep IgG optimized using 1M 2-MEA at pH 4.5.
• Rabbit IgG required the stronger reductant TCEP, with optimal conditions found at 35 mM for anti-myoglobin antibodies.
• Produced anti-myoglobin half-IgG fragments maintained their antigen-binding activity.

Conclusions:

• Tailored reduction conditions, including pH and specific reductants (2-MEA or TCEP), are crucial for maximizing half-antibody fragment yields from different IgG subclasses.
• Optimized protocols enable efficient generation of functional half-antibody fragments for diverse biotechnological applications.
• The study provides a foundation for developing specific, high-yield antibody fragmentation methods.